BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 7540057)

  • 21. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
    Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
    Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radioimmunoassay of HCG and HCG beta in blood during pregnancy and trophoblastomas].
    Mputu L; Thomas K; Renaer M; Vorstermans M; de Muylder X; Ferin J
    J Gynecol Obstet Biol Reprod (Paris); 1977 Sep; 6(6):777-91. PubMed ID: 199644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
    Ngan HY; Wong LC
    Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
    Goldstein DP; Pastorfide GB; Osathanondh R; Kosasa TS
    Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of remission in trophoblastic disease as seen from serum hCG level (author's transl)].
    Hirashima N
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):592-600. PubMed ID: 6263999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management and outcome of healthy women with a persistently elevated beta-hCG.
    Palmieri C; Dhillon T; Fisher RA; Young AM; Short D; Mitchell H; Aghajanian C; Savage PM; Newlands ES; Hancock BW; Seckl MJ
    Gynecol Oncol; 2007 Jul; 106(1):35-43. PubMed ID: 17482245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of the malignant form of trophoblastic disease after a hydatidiform mole: systematic or selective chemotherapy].
    Delvoye P; Robyn C
    J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):267-93. PubMed ID: 181422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
    Lambert-Messerlian G; Pinar H; Rubin LP; De Paepe ME; Tantravahi U; Steinhoff MM; Russell M; Canick JA
    Pediatr Dev Pathol; 2005; 8(2):230-4. PubMed ID: 15765203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report.
    Sasaki S; Sasaki Y; Iino K
    J Reprod Med; 2010; 55(7-8):317-20. PubMed ID: 20795345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
    Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K; Satgunasingam N; Nasri NM; Ng KY
    Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P; Leyendecker G
    Arch Gynecol; 1979 Jul; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract]   [Full Text] [Related]  

  • 39. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
    Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH; Cannon W; Benedet JL; Boyes DA
    Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.